Telithromycin-resistantStreptococcus pneumoniae
Open Access
- 1 September 2005
- journal article
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 11 (9) , 1489-1490
- https://doi.org/10.3201/eid1109.050415
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Pharmacodynamic Activity of Telithromycin at Simulated Clinically Achievable Free-Drug Concentrations in Serum and Epithelial Lining Fluid against Efflux ( mefE )-Producing Macrolide- Resistant Streptococcus pneumoniae for Which Telithromycin MICs VaryAntimicrobial Agents and Chemotherapy, 2005
- Influence of Carbon Dioxide on the MIC of Telithromycin for Streptococcus pneumoniae : an In Vitro - In Vivo StudyAntimicrobial Agents and Chemotherapy, 2005
- Activities of Telithromycin against 13,874 Streptococcus pneumoniae Isolates Collected between 1999 and 2003Antimicrobial Agents and Chemotherapy, 2004
- Macrolide resistance and genotypic characterization of Streptococcus pneumoniae in Asian countries: a study of the Asian Network for Surveillance of Resistant Pathogens (ANSORP)Journal of Antimicrobial Chemotherapy, 2004
- What is the clinical impact of macrolide resistance?Current Infectious Disease Reports, 2004
- Overcoming antimicrobial resistance: profile of a new ketolide antibacterial, telithromycinJournal of Antimicrobial Chemotherapy, 2001
- Penicillin-resistant Streptococcus pneumoniae: selection by both β-lactam and non-β-lactam antibioticsJournal of Antimicrobial Chemotherapy, 1999
- INCREASED RESISTANCE OF STREPTOCOCCUS PNEUMONIAE TO ANTIBIOTICS AND PREVALENCE OF THEIR CAPSULAR SEROTYPES1978